Back to AB Abrams Capital Management, L.P.
TEVA
Showing 0 of 19 quarters
Position history for ABAbrams Capital Management, L.P.'s holdings in Teva Pharmaceutical Industries Limited
No. Abrams Capital Management exited its TEVA (Teva Pharmaceutical Industries) position in Q1 2024. Its Q4 2023 13F listed 5,996,836 shares worth $62.6M. Abrams Capital Management already held TEVA in its Q3 2019 13F, the earliest on record, and held it in 18 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.